In March 2025, The Lancet Respiratory Medicine published a phase 2 clinical study article on China's first DPP-1 inhibitor, HSK31858, led by Academician Nan-shan Zhong and Professor Wei-jie Guan from ...
AmberFin has introduced of group of new file-based media ingest and transcode products that support the Digital Production Partnership (DPP) initiative. AmberFin is the first vendor to introduce a DPP ...
Bronchiectasis is one of the most common highly heterogeneous chronic inflammatory airway diseases in China. It has a long course, heavy symptom burden, and is prone to recurrent acute exacerbations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback